Sino Biopharmaceutical Limited
SBMFF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $89,473,731 | $59,378,114 | $51,730,002 | $56,872,816 |
| - Cash | $19,823,304 | $19,823,304 | $9,569,584 | $9,569,584 |
| + Debt | $11,955,911 | $11,955,911 | $9,783,841 | $9,783,841 |
| Enterprise Value | $81,606,338 | $51,510,721 | $51,944,259 | $57,087,073 |
| Revenue | $8,787,389 | $8,787,389 | $6,495,878 | $6,495,878 |
| % Growth | 0% | 35.3% | 0% | – |
| Gross Profit | $7,246,847 | $7,246,847 | $5,250,159 | $5,250,159 |
| % Margin | 82.5% | 82.5% | 80.8% | 80.8% |
| EBITDA | $1,969,192 | $1,969,192 | $1,084,489 | $1,090,124 |
| % Margin | 22.4% | 22.4% | 16.7% | 16.8% |
| Net Income | $1,694,296 | $1,694,296 | $241,336 | $241,336 |
| % Margin | 19.3% | 19.3% | 3.7% | 3.7% |
| EPS Diluted | 0.094 | 0.094 | 0.014 | 0.014 |
| % Growth | 0% | 571.4% | 0% | – |
| Operating Cash Flow | $1,580,224 | $1,580,224 | $0 | $0 |
| Capital Expenditures | -$135,425 | -$135,425 | $0 | $0 |
| Free Cash Flow | $1,444,799 | $1,444,799 | $0 | $0 |